Business
Alarm as FDA willing to issue Covid-19 vaccine before stringent safety testing – The Guardian
FDA under intensifying pressure from Trump, who wants to see a vaccine come on stream or ready to announce before the election
Public health experts have reacted with alarm to remarks by the head of the US Food and Drug Administration (FDA) that he might give the green light for a US Covid-19 vaccine before the normal clinical trial process had reached its conclusion.
As the US was on the verge of 6m coronavirus cases on Sunday, Stephen Hahn, the FDA commissioner, told the Financial Times in an interview published on Sunday that he was prepared to issue emergency use authorization for a Covid-19 vaccine before the end …
-
Noosa News17 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
General22 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News14 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
Business17 hours agoHow did the market react to this dividend stock’s earnings results?